Navigation Links
Rib-X Pharmaceuticals Novel Antibiotic Delafloxacin Named One of R&D Directions 100 Great Investigational Drugs of 2009
Date:4/2/2009

NEW HAVEN, Conn., April 2 /PRNewswire/ -- Rib-X Pharmaceuticals, Inc. ("Rib-X" or the "Company"), a development-stage company focused on the discovery and development of novel antibiotics for the treatment of antibiotic-resistant infections, today announced that its lead compound, delafloxacin, has been selected by R&D Directions editors for the 8th annual report on "100 Great Investigational Drugs," published in the March 2009 issue.

R&D Directions is a leading pharmaceutical industry magazine. Compounds selected by editors for the report, including delafloxacin, demonstrated "particular promise in a... growing therapeutic area of unmet medical need... and target disease pathways using a distinctly innovative mechanism of action."(1)

"We are honored to have our lead compound, delafloxacin, recognized by the editors of R&D Directions as one of the top 100 investigational drugs of 2009," said Susan Froshauer, PhD, President and CEO of Rib-X Pharmaceuticals. "The broad spectrum activity demonstrated by delafloxacin against a wide range of highly-resistant bacteria may offer the medical community a much needed treatment alternative for a variety of serious hospital treated infections, including complicated skin, hospital acquired pneumonia, endocarditis and others. We are proud of the work we have done at Rib-X to further the development of this compound."

A copy of the R&D Directions 100 Great Investigational Drugs of 2009 report can be viewed at http://www.rddirections.com/magazines/randd/.

About Delafloxacin

Delafloxacin, a novel, broad spectrum, next-generation fluoroquinolone, has demonstrated better activity than other quinolones against Gram-positive bacteria, including isolates of MRSA that are re
'/>"/>

SOURCE Rib-X Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Rib-X Pharmaceuticals Reports Positive Top-Line Results from Phase 2 Study of Delafloxacin
2. Rib-X Pharmaceuticals Reports Positive Phase 2 Study Results for Next Generation Oxazolidinone at 2008 ICAAC/IDSA Joint Meeting
3. Rib-X Pharmaceuticals, Inc. Announces Recent and Upcoming Presentations at Scientific Conferences
4. Rib-X Pharmaceuticals Initiates Phase 2 Trial for RX-3341 In Complicated Skin and Skin Structure Infections
5. Rib-X Pharmaceuticals Renews Collaborative Agreement with the Medical Research Council
6. Rib-X Pharmaceuticals to Present at 10th Annual Superbugs & Superdrugs Conference
7. Arena Pharmaceuticals to Host Conference Call and Webcast on Monday, March 30, 2009 to Discuss Lorcaserin Pivotal Phase 3 Obesity Trial Results
8. Oramed Pharmaceuticals to Present Oral Insulin Phase 2A Trial Results at the Upcoming Annual Meeting of the ADA (June 5-9, New Orleans, LA)
9. XTL Biopharmaceuticals Announces the Acquisition of the Use Patent on Recombinant Erythropoietin (rHuEPO) for the Treatment of Multiple Myeloma
10. Poniard Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results and Provides a Corporate Update
11. Avineuro Pharmaceuticals, Inc. Announces Beginning of Phase I Clinical Studies of AVN-211, Potent Small Molecule for Treatment of Schizophrenia.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)...  Ardelyx, Inc. (NASDAQ: ARDX ), a clinical-stage ... today announced that the Company will host its inaugural ... 1:00 pm EDT in New York City ... team will present an overview of the Company,s pipeline ... Phase 2b clinical trials for the treatment of patients ...
(Date:6/30/2015)... Fla. , June 30, 2015  July 4 th ... declaration of independence, and the spirit and people behind it. ... Foundation has partnered with USA Medical ... help increase funding for programs that empower independence for our ... country, and help more people afford their prescriptions. ...
(Date:6/30/2015)... WAYNE, Pa. , June 30, 2015 ... ("Egalet"), a fully integrated specialty pharmaceutical company ... pain treatments, today announced top-line results from ... study of Egalet-002, an abuse-deterrent, extended-release, oral ... for the management of pain severe enough ...
Breaking Medicine Technology:Ardelyx to Host Inaugural R&D Investor Day in New York City on July 14, 2015 2Hope For Heroes and USA Medical Card Make a Difference for Our Nation's Heroes 2Egalet Announces Top-Line Results from Oral Human Abuse Liability Study of Egalet-002 2Egalet Announces Top-Line Results from Oral Human Abuse Liability Study of Egalet-002 3Egalet Announces Top-Line Results from Oral Human Abuse Liability Study of Egalet-002 4Egalet Announces Top-Line Results from Oral Human Abuse Liability Study of Egalet-002 5
... Targeting Pro-Inflammatory,Protein -, GAITHERSBURG, Md., April 18, ... publication of preclinical,study data demonstrating a role ... nuclear DNA-binding protein, in the pathology,of systemic ... or lupus) and rheumatoid arthritis. Data to ...
... RIDGE, N.J., April 19, 2007 /PRNewswire-FirstCall/ --,VioQuest ... focused on acquiring, developing and,commercializing targeted cancer ... VQD- 002, a direct inhibitor of Akt,activation ... tumors.,Pre-clinical data was presented in a poster ...
Cached Medicine Technology:MedImmune Publishes New Data in Nature Immunology Demonstrating The,Role HMGB1 May Play in Systemic Autoimmune Diseases 2MedImmune Publishes New Data in Nature Immunology Demonstrating The,Role HMGB1 May Play in Systemic Autoimmune Diseases 3VioQuest Pharmaceuticals Announces Data Presentation for Its Akt,Inhibitor VQD-002, at American Association for Cancer Research,Annual Meeting 2VioQuest Pharmaceuticals Announces Data Presentation for Its Akt,Inhibitor VQD-002, at American Association for Cancer Research,Annual Meeting 3VioQuest Pharmaceuticals Announces Data Presentation for Its Akt,Inhibitor VQD-002, at American Association for Cancer Research,Annual Meeting 4VioQuest Pharmaceuticals Announces Data Presentation for Its Akt,Inhibitor VQD-002, at American Association for Cancer Research,Annual Meeting 5
(Date:6/30/2015)... ... July 01, 2015 , ... Popular review portal ... navigate. By making fundamental changes to the UI, the website hopes to benefit ... “Finding the right website has been getting tougher. People are seeking professional assistance ...
(Date:6/30/2015)... ... June 30, 2015 , ... Ticket Down is a reputable source of authentic Kid Rock ... Kid Rock, is hitting the road again this summer in what is one of the ... kicked off his summer tour this year at the XFINITY Theatre in Hartford, CT on ...
(Date:6/30/2015)... ... June 30, 2015 , ... Ticket Down is a reliable source for last minute tickets ... has been packing stadiums across North America in conjunction with their 2015 “Zip Code Tour.” ... energy of a band in their twenties. Some of the most beloved songs that ...
(Date:6/30/2015)... ... 2015 , ... According to research by European archeologists that was recently discussed ... four hundred thousand years ago likely knew that eating a balanced diet and limiting ... ancient dental plaque, researchers were able to find evidence of plant fibers, in addition ...
(Date:6/30/2015)... , ... June 30, 2015 , ... ... one of Medicare’s top-rated care centers in the country. To spread the word, ... satisfaction and proving its facility is, indeed, worthy of five stars. While Medicare ...
Breaking Medicine News(10 mins):Health News:HerpesDatingSites.org Introduces a New Responsive Design 2Health News:Cheap Kid Rock Tickets at the DTE Energy Music Theatre in Clarkston: Ticket Down Has Slashed Prices On All Kid Rock Tickets at DTE in the Detroit Metro Area 2Health News:The Rolling Stones Tickets in Raleigh at Carter Finley Stadium: Ticket Down Offers Last Minute Tickets for the Rolling Stones and Avett Brothers in Raleigh 2Health News:Recent Article Detailing Research on 400,000 Year Old Dental Plaque Shows Ancestral Understanding of Healthy Eating and Basic Oral Hygiene, Says Feiz Dental 2Health News:Recent Article Detailing Research on 400,000 Year Old Dental Plaque Shows Ancestral Understanding of Healthy Eating and Basic Oral Hygiene, Says Feiz Dental 3Health News:Villa Health Care Center Announces Highest Care Rating in New Video 2
... Research Hospital, and Help Kick Off the Fourth Annual ... be Held Monday, Nov. 19 at 11 a.m. at the ... Visitors to Bryant Park on,Monday morning will have the chance ... finishing touches on a three-dimensional canvas mural derived,from a new ...
... National Competition to Raise Radon Awareness, HARRISBURG, ... to national competition after winning the state,s,radon poster ... this,potentially dangerous gas., "I congratulate these students ... aware of radon, and I urge everyone to ...
... ,Green, Design and Operations a Principle Objective for ... ... Nov. 15 Architects and,engineers SMRT Inc. http://www.smrtinc.com/ of ... http://www.gehealthcare.com/ to,design a new digital X-ray detector production facility in ...
... Winston,Laboratories, Inc., a specialty pharmaceutical company engaged ... management, and Getting,Ready Corporation (OTC Bulletin Board: GTRY), ... a merger agreement that will bring,the two companies ... renamed,Winston Pharmaceuticals, Inc., and will be headquartered in ...
... 15 Governor Sonny Perdue today,released a proclamation ... an initiative of the Center for,Health Transformation, founder ... presented at a ceremony honoring the achievement of ... has led to significant,strides toward improving the quality ...
... for Low,Income Subsidies, Enhanced Publications and Online Tools, ... of,Health and Human Services (HHS) announced that, beginning ... enrollment changes in their,health and prescription drug coverage ... Period for prescription drug plan runs from Nov. ...
Cached Medicine News:Health News:American Airlines Invites the Public to Join Marlo Thomas and St. Jude Patients to Create One-of-a-Kind Mural to Celebrate 80 Years of Service in the Greater New York Area 2Health News:American Airlines Invites the Public to Join Marlo Thomas and St. Jude Patients to Create One-of-a-Kind Mural to Celebrate 80 Years of Service in the Greater New York Area 3Health News:American Airlines Invites the Public to Join Marlo Thomas and St. Jude Patients to Create One-of-a-Kind Mural to Celebrate 80 Years of Service in the Greater New York Area 4Health News:PA DEP Secretary Announces Pennsylvania's Radon Poster Contest Winners 2Health News:SMRT Architects and Engineers Selected to Design New $115M Digital X-Ray Manufacturing Facility for GE Healthcare 2Health News:Getting Ready Corporation and Winston Laboratories, Inc. Announce Merger Agreement 2Health News:Getting Ready Corporation and Winston Laboratories, Inc. Announce Merger Agreement 3Health News:Getting Ready Corporation and Winston Laboratories, Inc. Announce Merger Agreement 4Health News:Nationally-Recognized Georgia Diabetes Project Honored 2Health News:Nationally-Recognized Georgia Diabetes Project Honored 3Health News:Nationally-Recognized Georgia Diabetes Project Honored 4Health News:2008 Open Enrollment for Medicare Part D Prescription Drug Coverage and Medicare Advantage Plans Begins Today 2Health News:2008 Open Enrollment for Medicare Part D Prescription Drug Coverage and Medicare Advantage Plans Begins Today 3Health News:2008 Open Enrollment for Medicare Part D Prescription Drug Coverage and Medicare Advantage Plans Begins Today 4
The CKMB method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of creatine kinase MB isoenzyme activity in serum and plasma...
For the quantitative in vitro determination of Cholesterol in serum and plasma....
The ALP method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of alkaline phosphatase activity in serum or plasma....
The Tag-It™ Cystic Fibrosis ASR reagents can be used by high complexity CLIA approved laboratories for detection of up to 70 mutations and 6 variants (polymorphisms) in the cystic fibrosis tran...
Medicine Products: